EPISODE · Apr 27, 2022 · 11 MIN
Atara Planning Phase 3 Trials of ATA188 in Non-active SPMS, PPMS & Seizing the Day With MS
from MS News & Perspectives · host MS News Today
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how Atara may open two Phase 3 clinical trials of ATA188, an immunotherapy targeting EBV-infected B-cells in non-active progressive MS patients.He also reads “Upon Reflection, I’m Determined to Seize the Day” from "The MS Wire," a column by Ed Tobias.=================================== Are you interested in learning more about multiple sclerosis? If so, please visit:https://multiplesclerosisnewstoday.com/ =====================================To join in on conversations regarding multiple sclerosis, please visit:https://multiplesclerosisnewstoday.com/forums/
NOW PLAYING
Atara Planning Phase 3 Trials of ATA188 in Non-active SPMS, PPMS & Seizing the Day With MS
No transcript for this episode yet
Similar Episodes
Apr 21, 2026 ·13m
Apr 19, 2026 ·16m
Apr 17, 2026 ·13m
Apr 13, 2026 ·11m
Apr 11, 2026 ·16m